Table 1.
Variables | N (%)* |
Study type | |
Peer-reviewed | 194 (40) |
Report or survey | 294 (60) |
Region (Global Burden of Disease super regions) | |
Central Europe, Eastern Europe and Central Asia | 75 (15) |
High Income | 300 (61) |
Latin America and Caribbean | 27 (6) |
North Africa and Middle East | 20 (4) |
South Asia | 9 (2) |
Southeast Asia, East Asia and Oceania | 25 (5) |
Sub-Saharan Africa | 32 (7) |
Prevalence | |
Any prevalence period | 484 (99) |
Unclear prevalence period | 4 (1) |
Point prevalence | 57 (12) |
Incidence | 9 (2) |
Age groups | |
0–4 | 28 (6) |
5–9 | 33 (7) |
10–14 | 214 (44) |
15–19 | 385 (79) |
20–24 | 256 (52) |
25–29 | 264 (54) |
30–34 | 270 (55) |
35–39 | 273 (56) |
40–44 | 281 (58) |
45–49 | 287 (59) |
50–54 | 297 (61) |
55–59 | 294 (60) |
60–64 | 286 (59) |
65–69 | 276 (57) |
70–74 | 268 (55) |
75–79 | 257 (53) |
80–84 | 245 (50) |
85–89 | 243 (50) |
90–94 | 241 (49) |
95+ | 240 (49) |
Data for both genders available | 472 (97) |
Representative sample | 446 (91) |
Acceptable low back pain definition | 79 (16) |
*Numbers do not add up to the total number of reports (488) because some reports measured more than one prevalence period.